文献速递血液净化与透析

校正残余肾尿素清除率的标准化蛋白分解代谢率与血清白蛋白及透析患者死亡率的纵向关联

Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-05-10

在美国36757例新发血液透析患者中,研究基线及6个月内校正残余肾尿素清除率的nPCR变化与血清白蛋白和5年死亡率的关系。结果显示,基线校正nPCR较高及6个月内上升幅度较大均与更高血清白蛋白和更低死亡率相关;未校正肾尿素清除率会低估nPCR,校正nPCR可能是更好的死亡标志物。

要点

  • 校正肾尿素清除率的nPCR较未校正者中位高0.14 g/kg/天,未校正会低估蛋白摄入。
  • 基线校正nPCR较高与血清白蛋白更高及死亡率更低独立相关(Ptrend<0.001)。
  • 6个月内校正nPCR上升≥0.5 g/kg/天者死亡风险更低(HR 0.76,95%CI 0.64-0.90)。

核心结论

  • 在新发血透患者中,以校正肾尿素清除率的nPCR反映的膳食蛋白摄入及其随时间变化与更高血清白蛋白和更好生存相关。
  • 未校正肾尿素清除率会低估nPCR,校正nPCR可能比传统nPCR是更好的死亡标志物。

研究设计与样本

  • 回顾性纵向队列研究,纳入美国一家大型透析组织36,757例新发血液透析患者,观察基线及6个月内校正肾尿素清除率的nPCR变化,随访5年(2007年1月至2011年12月)。

主要发现

  • 基线校正与未校正nPCR中位数分别为0.94和0.78 g/kg/天,患者内中位差异0.14(四分位距0.07-0.23)g/kg/天。
  • 中位随访1.4年期间观察到8481例死亡。
  • 基线校正nPCR与更高血清白蛋白和更低死亡率相关(完全校正模型Ptrend<0.001)。
  • 在13,895例有数据患者中,6个月内校正nPCR上升幅度较大与达到高血清白蛋白(≥3.8 g/dl)及更低死亡率相关(Ptrend<0.001)。
  • 与参考组(变化0.1-0.2 g/kg/天)相比,变化<-0.2 g/kg/天者达到高白蛋白的OR为0.53(95%CI 0.44-0.63)、死亡HR为1.32(95%CI 1.14-1.54);变化≥0.5 g/kg/天者OR为1.62(95%CI 1.35-1.96)、HR为0.76(95%CI 0.64-0.90)。

关键数值与推荐

  • 在未校正nPCR的任一类别内,校正nPCR较高者死亡率风险 consistently 更低。

临床怎么用

  • 评估血透患者蛋白摄入时,应考虑使用校正残余肾尿素清除率的nPCR,以避免低估。
  • 动态监测校正nPCR变化可能有助于识别低白蛋白和高死亡风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: There are inconsistent reports on the association of dietary protein intake with serum albumin and outcomes among patients on hemodialysis. Using a new normalized protein catabolic rate (nPCR) variable accounting for residual renal urea clearance, we hypothesized that higher baseline nPCR and rise in nPCR would be associated with higher serum albumin and better survival among incident hemodialysis patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Among 36,757 incident hemodialysis patients in a large United States dialysis organization, we examined baseline and change in renal urea clearance-corrected nPCR as a protein intake surrogate and modeled their associations with serum albumin and mortality over 5 years (1/2007-12/2011). RESULTS: Median nPCRs with and without accounting for renal urea clearance at baseline were 0.94 and 0.78 g/kg per day, respectively (median within-patient difference, 0.14 [interquartile range, 0.07-0.23] g/kg per day). During a median follow-up period of 1.4 years, 8481 deaths were observed. Baseline renal urea clearance-corrected nPCR was associated with higher serum albumin and lower mortality in the fully adjusted model (Ptrend<0.001). Among 13,895 patients with available data, greater rise in renal urea clearance-corrected nPCR during the first 6 months was also associated with attaining high serum albumin (≥3.8 g/dl) and lower mortality (Ptrend<0.001); compared with the reference group (a change of 0.1-0.2 g/kg per day), odds and hazard ratios were 0.53 (95% confidence interval, 0.44 to 0.63) and 1.32 (95% confidence interval, 1.14 to 1.54), respectively, among patients with a change of <-0.2 g/kg per day and 1.62 (95% confidence interval, 1.35 to 1.96) and 0.76 (95% confidence interval, 0.64 to 0.90), respectively, among those with a change of ≥0.5 g/kg per day. Within a given category of nPCR without accounting for renal urea clearance, higher levels of renal urea clearance-corrected nPCR consistently showed lower mortality risk. CONCLUSIONS: Among incident hemodialysis patients, higher dietary protein intake represented by nPCR and its changes over time appear to be associated with increased serum albumin levels and greater survival. nPCR may be underestimated when not accounting for renal urea clearance. Compared with the conventional nPCR, renal urea clearance-corrected nPCR may be a better marker of mortality.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Eriguchi R, Obi Y, Streja E, et al. Longitudinal Associations among Renal Urea Clearance-Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2017. PMID: 28490436. doi:10.2215/CJN.13141216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。